These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7971512)
1. [Testing the efficacy of fluconazole in treatment of oral and throat candidiasis in patients after kidney transplantation]. Michnowska M; Klin MJ; Mroczka T; Mularczyk E; Lao M Pol Tyg Lek; 1993 Dec 13-27; 48(50-52):867-9. PubMed ID: 7971512 [TBL] [Abstract][Full Text] [Related]
2. [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)]. Sow PS; Diop BM; Ndiaye I; Faye MA; Coll-Seck AM Dakar Med; 1993; 38(1):85-8. PubMed ID: 7882856 [TBL] [Abstract][Full Text] [Related]
3. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. Jandourek A; Vaishampayan JK; Vazquez JA AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200 [TBL] [Abstract][Full Text] [Related]
5. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757 [TBL] [Abstract][Full Text] [Related]
6. [Fluconazole in therapy of candidiasis of the oropharyngeal space in patients with HIV infection. Results of an open multicenter study of assessing the effectiveness and tolerance of fluconazole]. Tschechne B; Brunkhorst U; Ruhnke M; Trautmann M; Dempe S; Deicher H Med Klin (Munich); 1991 Oct; 86(10):508-11. PubMed ID: 1758372 [TBL] [Abstract][Full Text] [Related]
7. Itraconazole and fluconazole in oropharyngeal candidiasis. van der Bijl P; Arendorf TM Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372 [TBL] [Abstract][Full Text] [Related]
8. Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial. Studena V; Sycova Z; Helpianska L; Sorkovska D; Pichna P; Lacka J; Hlavacova E; Oravcova E; Krcmery V; Studena M J Chemother; 1995 Nov; 7 Suppl 4():204-5. PubMed ID: 8904157 [No Abstract] [Full Text] [Related]
9. Fluconazole found effective against candidiasis. Oncology (Williston Park); 1989 Nov; 3(11):112. PubMed ID: 2561879 [No Abstract] [Full Text] [Related]
10. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ; Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489 [TBL] [Abstract][Full Text] [Related]
11. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [TBL] [Abstract][Full Text] [Related]
12. A case of oral erosive candidosis in a kidney transplant patient. Romano C; Ghilardi A; Carcagnì MR; De Aloe GB Mycoses; 2004 Dec; 47(11-12):524-6. PubMed ID: 15601462 [TBL] [Abstract][Full Text] [Related]
13. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients. Blignaut E; Botes ME; Nieman HL SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568 [TBL] [Abstract][Full Text] [Related]
14. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis]. Corzo Delgado JE; Lozano de León F; Aretio Najarro R; Martín Mazuelos E Med Clin (Barc); 1994 Nov; 103(16):639. PubMed ID: 7996928 [No Abstract] [Full Text] [Related]
15. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500 [TBL] [Abstract][Full Text] [Related]
17. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Fichtenbaum CJ; Koletar S; Yiannoutsos C; Holland F; Pottage J; Cohn SE; Walawander A; Frame P; Feinberg J; Saag M; Van der Horst C; Powderly WG Clin Infect Dis; 2000 May; 30(5):749-56. PubMed ID: 10816143 [TBL] [Abstract][Full Text] [Related]
18. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Seidman LS; Skokos CK Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779 [TBL] [Abstract][Full Text] [Related]